^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CART-TM4SF1

    i
    Other names: CART-TM4SF1, TM4SF1-positive chimeric antigen receptor T-cell therapy
    Associations

    News

    Trials
    Company:
    Shanghai Ultra-T Immune Therap
    Drug class:
    TM4SF1-targeted CAR-T immunotherapy
    Associations

    News

    Trials
    3years
    A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1-positive Tumors of Digestive System (clinicaltrials.gov)
    P=N/A, N=24, Not yet recruiting, Changhai Hospital
    New trial
    |
    IFIT3 (Interferon Induced Protein With Tetratricopeptide Repeats 3) • TM4SF1 (Transmembrane 4 L Six Family Member 1)
    |
    TM4SF1 expression
    |
    CART-TM4SF1